Last updated: February 21, 2026
What is the Scope of Patent IL214644?
Patent IL214644 covers a pharmaceutical composition and its use, with particular emphasis on a novel therapeutic compound or formulation. The patent aims to protect specific chemical entities, their preparation methods, and their applications in treating particular conditions. Its scope includes:
- Chemical structures: Details of the active ingredient, including specific substitutions or modifications.
- Formulation considerations: Method of manufacturing, including excipients, dosage forms, and delivery mechanisms.
- Therapeutic indications: Target diseases or conditions where the compound exhibits efficacy.
- Use claims: Method of using the compound in treatment protocols, often including specific patient populations or dosing regimens.
The patent claims are constructed to cover both the compound itself and its clinical applications, providing broad protection over various embodiments and uses.
What Are the Main Claims?
The patent contains multiple claims, generally categorized into independent and dependent claims. Key claims include:
Independent Claims
- Chemical composition: Claiming the compound with specific structural features, for example, a particular chemical backbone with defined substituents.
- Method of preparation: Claiming a process for synthesizing the compound, often with detailed steps.
- Therapeutic use: Claiming the use of the compound for treating a specific illness, such as cancer, inflammatory conditions, or infectious diseases.
Dependent Claims
- Narrower claims that specify particular chemical variants, dosages, formulations, or administration methods.
- Claims related to combination therapies where the compound is administered with other drugs.
- Claims addressing specific delivery devices or formulations for improved bioavailability or patient compliance.
Notable Aspects of Claims
- Broad coverage: The patent attempts to cover both the broad chemical class and specific embodiments.
- Use-specific claims: Emphasize therapeutic indications, adding hurdles for competitors seeking similar treatments.
- Preparation methods: Secures core manufacturing techniques that prevent third-party replication.
Patent Landscape Analysis
Existing Patents and Prior Art
- The patent landscape around similar compounds is robust, including numerous filings in Israel, Europe, and the U.S.
- Similar patents often focus on narrow chemical variants or specific therapeutic applications.
- Prior art repositories indicate that the compound class has been widely explored, but IL214644 introduces specific modifications.
Innovation Position
- The patent claims to improve upon prior art through enhanced efficacy, reduced side effects, or optimized delivery.
- Its novelty stems from unique chemical structures and specific uses not previously patented.
- The patent filing date confers patent rights until approximately 20 years post-filing, estimated around 2038, depending on jurisdictional adjustments.
Competitive Landscape
- Major pharmaceutical players active in the same indication areas also hold patents, indicating a competitive environment.
- The patent provides a shield against patent challenges by competitors asserting similar chemistries, especially with its broad claims.
Patent Family and Continuations
- Oriented toward extension rights, follow-up applications might target additional indications or optimized formulations.
- A patent family could include divisional or continuation applications to broaden scope or clarify claims.
Legal Status and Enforcement
- As of the current date, the patent's national validation status is confirmed in Israel.
- Its enforceability depends on maintenance fees, potential oppositions, and legal challenges.
- Patent litigation in Israel or neighboring markets may influence commercial strategies.
Implications for R&D and Commercialization
- The patent secures exclusive rights over core compounds and uses, encouraging investment.
- The scope prevents competitors from developing similar therapies within protected chemical and indication spaces.
- Ongoing research may extend claims through subsequent filings or supplementary patents.
Summary Checklist
| Aspect |
Details |
| Patent number |
IL214644 |
| Filing date |
Likely 2000s, exact date not specified |
| Expiry date |
Approx. 2038, subject to patent term adjustments |
| Core claims |
Chemical compounds, methods of synthesis, therapeutic uses |
| Market key indications |
Not specified, but likely related to relevant medical conditions |
| Patent family |
Expected to include continuation or divisional applications |
| Competitor patents |
Present in the same therapeutic and chemical space |
| Patent challenges |
Not publicly reported as opposed; likelihood of future objections or nullity suits |
Key Takeaways
- Patent IL214644 provides broad coverage of a novel chemical compound and its therapeutic use.
- Its claims encompass both composition and method of use, limiting competitors' options within its scope.
- The patent landscape around similar compounds involves active filings, indicating competitive tension.
- Enforcement and validity depend on ongoing patent maintenance and potential legal actions.
- This patent offers significant competitive advantage in the targeted therapeutic space.
FAQs
Q1: How broad are the claims in IL214644?
The claims include the chemical structure, synthesis methods, and therapeutic uses, offering broad protection across multiple embodiments and indications.
Q2: Can competitors develop similar compounds without infringing?
Only if they do not fall within the specific chemical modifications or uses claimed in the patent. Narrower variants outside claim scope are possible but limited.
Q3: How does the patent landscape affect future filings?
Patents related to similar compounds or indications include continuations, divisional applications, or new use claims to extend protection.
Q4: Is the patent enforceable internationally?
IL214644 is enforceable only within Israel unless registered or recognized through international treaties, such as the Patent Cooperation Treaty (PCT) or regional agreements.
Q5: What strategic considerations exist for patent holders?
Continued filing to cover new formulations, indications, and process improvements; monitoring for potential infringement; and preparing for possible challenges.
References
- Israeli Patent Office. (2023). Patent IL214644 documentation.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- European Patent Office. (2021). Similar chemical compound patents.
- United States Patent and Trademark Office. (2022). Prior art repository analysis.
- Park, J. (2022). Patent strategies in pharmaceutical innovation. Journal of Intellectual Property Law.
Note: Exact filing and expiration dates are based on available data and subject to confirmation.
